🇺🇸 FDA
Patent

US 11180518

Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma

granted A61KA61K31/415A61K31/4155

Quick answer

US patent 11180518 (Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma) held by Ludwig-Maximilians-Universitat Munchen expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ludwig-Maximilians-Universitat Munchen
Grant date
Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/415, A61K31/4155, A61K31/675, A61P